정맥 시술 기기 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

The global demand for Venous Procedure Devices Market is presumed to reach the market size of nearly USD 4.52 Billion by 2032 from USD 2.55 Billion in 2023 with a CAGR of 6.55% under the study period 2024-2032.

Venous procedure devices are small flexible tubes placed in large veins for patients who require frequent access to the bloodstream. They allow administration directly into more prominent veins. Venous procedure devices are most often used to administer medications such as chemotherapy drugs, antibiotics, pain medications, among others, administration of fluids and nutritional compounds, transfusion of blood products, and blood draws for diagnostic testing.

MARKET DYNAMICS

The global venous procedure devices market is projected to grow at a remarkable rate during the forecast period. The rising numbers of surgeries performed globally, rapidly increasing prevalence of lifestyle diseases, growing blood transfusion, rise in the number of patients seeking acute treatment, and escalating elderly population are factors accelerating demand for venous procedure devices. In addition, escalation product launches with utmost safety and efficiency and growing FDA approvals are also expected to drive the global order. But, high costs involved in the placement and maintenance of venous procedure devices and risks associated with vascular access devices obstruct market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Venous Procedure Devices. The growth and trends of Venous Procedure Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Venous Procedure Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)

• Catheters (Central Venous Catheter, Subcutaneous (Implanted) Port, Peripherally Inserted Central Catheter (PICC))
• Guidewires (Standard, High Support, Flexible, Chronic Total Occlusion)
• Others

By Product

• Vascular Disease (Chronic Deep Vein Thrombosis, Post-thrombotic Syndrome, Indication May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, Others)
• Cancer

By Application

• Leg
• Chest
• Abdomen
• Arm

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Venous Procedure Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Venous Procedure Devices market include Medtronic Plc, BD, Cardinal Health, TerumCorporation, Teleflex Incorporated, Boston Scientific Corporation, Optimed Medizinische Instrumente GmbH, Cook, BBraun Melsungen AG, Abbott Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. VENOUS PROCEDURE DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)
  • 3.7.2 Market Attractiveness Analysis By Product
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY VENOUS STENTS (DRUG ELUTING VENOUS STENT, NON-DRUG ELUTING VENOUS STENT)

• 5.1. Overview By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)
• 5.2. Historical and Forecast Data Analysis By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)
• 5.3. Catheters (Central Venous Catheter, Subcutaneous (Implanted) Port, Peripherally Inserted Central Catheter (PICC)) Historic and Forecast Sales By Regions
• 5.4. Guidewires (Standard, High Support, Flexible, Chronic Total Occlusion) Historic and Forecast Sales By Regions
• 5.5. Others Historic and Forecast Sales By Regions

6. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY PRODUCT

• 6.1. Overview By Product
• 6.2. Historical and Forecast Data Analysis By Product
• 6.3. Vascular Disease (Chronic Deep Vein Thrombosis, Post-thrombotic Syndrome, Indication May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, Others) Historic and Forecast Sales By Regions
• 6.4. Cancer Historic and Forecast Sales By Regions

7. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Leg Historic and Forecast Sales By Regions
• 7.4. Chest Historic and Forecast Sales By Regions
• 7.5. Abdomen Historic and Forecast Sales By Regions
• 7.6. Arm Historic and Forecast Sales By Regions

8. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY END USER

• 8.1. Overview By End User
• 8.2. Historical and Forecast Data Analysis By End User
• 8.3. Hospitals Historic and Forecast Sales By Regions
• 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 8.5. Specialty Clinics Historic and Forecast Sales By Regions
• 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE VENOUS PROCEDURE DEVICES COMPANIES

• 10.1. Venous Procedure Devices Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF VENOUS PROCEDURE DEVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Medtronic Plc
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. BD
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Cardinal Health
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. TerumCorporation
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Teleflex Incorporated
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Boston Scientific Corporation
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Optimed Medizinische Instrumente GmbH
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Cook
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. BBraun Melsungen AG
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Abbott Laboratories
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies